This is unpublished
Hansa Follow up Study
Active Studies
Actively Enrolling
Transplantation
Pinned
Principal Investigator
Nicolae Leca, MD
Funding Agency
Sponsor: Hansa Biopharma AB
Status
Active
Actively Enrolling
Investigator
What is the Hansa follow up Study?
A prospective, long-term confirmatory follow up trial in highly sensitized patients treated with imlifidase or standard of care in the ConfIdeS (20-HMedIdeS-17) trial.
What are the criteria for the study?
Participants must provide signed informed consent before any trial procedures and be randomized in the ConfIdeS trial.
WHO DO I CONTACT FOR MORE INFORMATION?
Research Coordinator
Nidhi Mehta
E: nidhim3@Nephrology.washington.edu